第一范文网 - 专业文章范例文档资料分享平台

泊洛沙姆407在制剂中的应用进展(4)

来源:用户分享 时间:2021-04-05 本文由仅是祈愿 分享 下载这篇文档 手机版
说明:文章内容仅供预览,部分内容可能不全,需要完整文档或者需要复制内容,请下载word后使用。下载word有问题请添加微信号:xxxxxx或QQ:xxxxxx 处理(尽可能给您提供完整文档),感谢您的支持与谅解。

第3期

ers/hyaluronieacid

insitu

forminghydrogel

for

drug

delivery:

Rheologieal,mueoadhesiveand

in

vitro

release

properties[J].

Eur

JPharmBioptmrm,2008,70(1):199-206.

[4]Ruel—Gari6pyE,LerouxJG.Insitu—forming

hydrngels--review

of

temperature—sensitive

systems[J].Ear

Pharm

Bioplmrm,

2004,58(2):409-426。

[5]

WankaG。HoffmannH。UlbriehtW.Phase

diagram

and

aggre—gation

behaviorof

poly(oxyethylene)-poly(oxypropylene)-poly

(oxyethylene)triblockcopolymemin

aqueous

solutions[J].

Macromolecules,1994,27(15):4145-4159,[6]AlexandridisP。Hatton

TA.Poly(ethyleneoxide)一poly(propyl-

ene

oxide)一poly(ethyleneoxide)block

eopolymer

surfaelmnts

in

aqueoulssolutionsand

at

interfaces:thermodynamics,stme—tore,dynamics,and

modeling[J].co如迅Surfh:Physicochem

EngAsp.1995。96(1-2):146.[7]

Mortensen

K,PedemenJS.Structuralstudy

on

themieelleforms-

lion

of

poly(ethyleneoxide)一poly(propyleneoxide)一poly(ethyl—

ene

oxide)triblockcopelymerinaquous

solution[J].Macromol-

eettle¥,1993,26(4):805-812.[8]

MaterialSafetyData

Sheetfor

Poloxamer407<Pluronic

F.127):

BASF

Corporation[EB/OL].http://www.sciencelab.cam/

xMSDS —Poloxamer_407—.9926616

[9]BlonderJM.,BairdL,FulfsJC,et01.Dose—dependenthyper-

lipidemia

in

rabbitsfollowingadministration

of

Poloxamer407gel

[J].LifeSci,1999,65(21):261-266,

[10]

陈祖基.重视眼部给药系统的研究[J].中华眼科杂志,2006,42(4):292-295.

[1i]KimJ.ChauhanA.Dexamethasone

transport

andoculardellt

ery

from

pely(hydroxyethylmethacrylate)gels[J].胁.,

Pharm,2008,353(1-2):205-222.

[12]

李索霞,曹德英,王刚.跟用即型凝胶的研究进展[J].中国医院药学杂志,2008,28(3):228-230.

[13]

QiH,ChenW,HuangC,eta1.Developmentof

peloxamer

analogs/earbopol-basedinsitu

gelling

andmueoadhesiveoph-

thalmiedelivery

system

for

puerarin[J].触JPharm,2007,

337(1-2):178—187.

[14]

KamelAH.In“troand轨vivaevaluationofPIuronicF127.

based

ocular

deliverysystem

forfimolol

maleate[J].,眦.,Pharm。2002,241(1):47.55.[15]MaWD。XuH,WangC,et以.PluronieF127一g-pely(acrylic

acid)eopelymers∞in

situ

gellingvehicteforophthalmicdmg

delivery

system[J].加JPharrn,2008,350(1_2):247-256.[16】宋成君,王莹,王春艳,等.黄芩温度敏感凝胶剂的研究

[J].中国中药杂志,2008,33(6):628-631.

[17]

孙海燕.利巴韦林体温敏感眼用凝胶的研制[D].沈阳:沈

阳药科大学,2005.

[18]StamatialisDF,BolevinkHH,KoopsG.H,Tranedermaltimo-

loldeliveryfrom

Pluronie

gel[J].J

Contro/Re/ease。2006.

116(2):e53.e55.

[19]

CafaggiS,RussoE,CaviglioliG,eta1.Poloxamer

407∞a

234

万方数据

金璐燕等,泊洛沙姆407在制剂中的研究进展

solubilisingagent

fortolfenamicacidand∞abase

fora

gelfor-

mulation[J].EurJPharmSci。2008,3s(1-2):19-29.

[20]

KimCK,LeeSW。Chat

HG,et

a/.Trialsofin

situ gellingand

mueoadhesiveacetaminophenhquidsuppositoryin

humansub—

jeets[J].胁JPharm,1999,174(1-2):201-207.

[21]

ChatHG,OhYK,Kim

CK.Insltu

gellingandmueoedhesive

liquid

suppositorycontaining

aeetaminophen:enhancedbioavail—

ability[J].IraJPharm,1998,165(1):23-32.

[22]

YunMO,ChatHG,JungJH,eta1.Developmentof

thermo—

reversibleinsulin

liquid

suppositorywithbioavailabilityenhance-

roent[J]./ntJPharrn,1999,189(2):137-145.

[23]

Ryu

JM,ChungSJ,Lee

MH,et

a/.Increasedbioavailability

of

proprandol

inrats

byretainingthermallygelling

liquidsupposi-

tortesin

therectum[J]..,Control

Re如ase,1999,59(2):163—

172.

[24]

FawazF,K0仿A,GuyotM,耐a/.Comparativeinvitro—inv/vo

study

of

twoquininerectal

gel

formulations[J].胁J

Pharm,

2004,280(1-2):151—162.[25]

ChangJY,Oh

YK,K0ng

HS,da/.Prolongedantifnngal

effects

of

elotrimazole—containingmueoadhesivethermosensitive

gels

on

vaginitis[J].,ControlRe如ease,2002,82(I):39-50.

[26]

王成伟,唐星,王晓梅,等.温度敏感性壬苯醇醚阴道用缓释凝胶的制备与评价[J].中国新药杂志,2006,15(4):280—

284.

[27]徐玉红,曾繁涛,王蔓琳,等.甲硝唑阴道用原位凝胶的处方

设计及体外质量评价[J].中国药师,2008,11(9):1025一

1027.

[28]VeyriesML,CouarrazeG,GeigerS,eta1.Controlledreleaseof

vaneomyeinfrom

Poloxamer407

gels[J].眈_,Pharm,1999.

192(2):183—193.

[29]

Lee

SH,LeeJE,Bank

WY,eta1.Regionaldelivery

of

van00-

myein

using

pluronieF一127

to

inhibitmethieiUin

resistant

Staph—

ylococcusaurens(MRSA)growth

in

chronicotitismediainvitro

andin

viva[j].JControlRelease,2004,96(1):1-7.

[30]

BoodhwaniM,FengJ,Mieno

S,eta1.Effectsofpurified

poloxamer407gel

onvasculalFocclusionandthe

coronaryendo-

thelium[J].EurJCardiothoracSurg,2006,29(5):736 741.

[31]OhtaS,NittaN,TakahashiM。et越.Pluronic

F127:Appliea-

lionin

Arterial

Embolization[J]。J

Vase

IntervRadial,2006,17

(3):533-539.

[32]

ZakiNM.,AwadGA.,Mortada

ND,et

a1.Enhancedbioavail—

ability

ofmetoclopramideHClbyintrantmal

administration

of

mueoadhesivein

situ

gelwithmodulatedtheologicaland

muco-

ciliary

transport

properties[J].EurJ

pharm蹦,2007,32(4-

5):296-307.

[333

MorishitaM,Bariehello

Jbl,TakayamaK,dd.Huronie

F-127

gehincorporating

hiSWypurifiedunsaturated

fatty

acidsforbuccal

deliveryof

insulin[J]./ntjPharm.2001,212(2):289-293.

(收稿日期:2009-03-05)

搜索“diyifanwen.net”或“第一范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读,第一范文网,提供最新高等教育泊洛沙姆407在制剂中的应用进展(4)全文阅读和word下载服务。

泊洛沙姆407在制剂中的应用进展(4).doc 将本文的Word文档下载到电脑,方便复制、编辑、收藏和打印
本文链接:https://www.diyifanwen.net/wenku/1177015.html(转载请注明文章来源)
热门推荐
Copyright © 2018-2022 第一范文网 版权所有 免责声明 | 联系我们
声明 :本网站尊重并保护知识产权,根据《信息网络传播权保护条例》,如果我们转载的作品侵犯了您的权利,请在一个月内通知我们,我们会及时删除。
客服QQ:xxxxxx 邮箱:xxxxxx@qq.com
渝ICP备2023013149号
Top